Prices rise for drugs used by elderly: studies

Share this Article


WASHINGTON (Reuters) – Prices of medicines used by older Americans for chronic conditions such as arthritis and high cholesterol are rising even as new federal drug coverage has been rolled out to help make prescriptions more affordable, two separate studies released on Tuesday showed. if (window.yzq_a == null) document.write(“”); if (window.yzq_a) { yzq_a(‘p’, ‘P=xYe0ns6.I3r_tjmCQ96P9g_qJnYogkShhz0ABpKb&T=1cksajfmd%2fX%3d1151436605%2fE%3d95864950%2fR%3dnews%2fK%3d5%2fV%3d1.1%2fW%3d8%2fY%3dYAHOO%2fF%3d3275795739%2fH%3dY2FjaGVoaW50PSJuZXdzIiBjb250ZW50PSJjaG9sZXN0ZXJvbDtkcnVnO2hlbHA7TWVkaWNhcmU7ZWxkZXJseTtBQVJQO2dvdmVybm1lbnQ7aW5zdXJhbmNlO0FtZXJpY2E7Ymxvb2QgcHJlc3N1cmU7SXQ7QW1lcmljYW47cmVmdXJsX25ld3NfeWFob29fY29tIiByZWZ1cmw9InJlZnVybF9uZXdzX3lhaG9vX2NvbSIgdG9waWNzPSJyZWZ1cmxfbmV3c195YWhvb19jb20i%2fS%3d1%2fJ%3d4D23BECE’); yzq_a(‘a’, ‘&U=139gvak6t%2fN%3dPT2jVc6.Iqs-%2fC%3d380976.7646779.8644240.1442997%2fD%3dLREC%2fB%3d3220573′); }

Researchers at Families USA found insurers participating in the Medicare drug benefit program raised overall prices 3.7 percent for the top 20 drugs used by the elderly since enrollment began in November.

Separately, the AARP found prices for nearly 200 of all drugs most used by the elderly — not just under Medicare — rose 3.9 percent from January through March. The AARP is the largest group representing older Americans.

The drug benefits program, which began in January, allows insurers to offer Medicare beneficiaries drug coverage with government oversight.

Participants are locked into a plan until annual open enrollment, although plans are allowed to change prices any time. Many patients were automatically transferred into the program, but about 11 million signed up individually.

“At the same time that the Bush administration and congressional leaders are touting the effectiveness of the Medicare drug plans, those plans are quietly raising the prices that they charge,” said Ron Pollack, director of Families USA.

The Centers for Medicare and Medicaid Services and an insurance industry group had no immediate comment on the studies.

Read article

Posted in: Uncategorized

Leave a Reply